# Insanitary Conditions at Compounding Facilities Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/insanitary-conditions-at-compounding-facilities-guidance-for-industry/6f8ff3c8-2f4a-49e4-a919-fc3c6b83579d

> FDA guidance document: Insanitary Conditions at Compounding Facilities Guidance for Industry. Issue date: November 06, 2020. Get complete insights and analysis.

---

## Details

- Title: Insanitary Conditions at Compounding Facilities Guidance for Industry
- Communication Type: Guidance Document
- Product Type: drugs
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2020-11-06
- Last Changed: 2020-11-06
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2016-D-2268">FDA-2016-D-2268</a>

## Related Documents

- [Requests for Reconsideration at the Division Level Under GDUFA](https://www.globalkeysolutions.net/guidances/guidance-document/requests-for-reconsideration-at-the-division-level-under-gdufa/57f559b5-e6c3-492b-91fd-01762f90e676)
- [Eosinophilic Esophagitis: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/eosinophilic-esophagitis-developing-drugs-for-treatment-guidance-for-industry/e454ac25-939f-4e9c-a8f1-b2613feff0b3)
- [Compounding and Repackaging of Radiopharmaceuticals By Outsourcing Facilities Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/compounding-and-repackaging-of-radiopharmaceuticals-by-outsourcing-facilities-guidance-for-industry/4a6e41fb-5d18-47fc-98b0-1dbe619a89b6)